Mild Cognitive Impairment (MCI)
169
49
54
40
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
1.8%
3 terminated out of 169 trials
93.0%
+6.5% vs benchmark
3%
5 trials in Phase 3/4
15%
6 of 40 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 40 completed trials
Clinical Trials (169)
Community-based Screening for Alzheimer's Disease
ADAI - Home Care in Intelligent Environments Clinical Care Ecosystem for the Management of Home Digital Therapies Through the Use of Assistive Robots and Clinical Predictive Systems Based on Artificial Intelligence Systems
Speech-Based Artificial Intelligence for Detection of Dementia in Danish Patients (DetectAI)
e-ALIGN: A Patient Portal-based Intervention to Align Medications With What Matters Most
Ketogenic Diet to Reduce Osteoarthritis Pain in MCI
Non-invasive Stimulation of Deep Brain Structures to Modulate Working Memory
Telemedicine Self-examination of Speech and Memory for Rapid Detection of Cognitive Impairments Using Machine Learning Methods
Personalized Digital Training for COGnitive FITness in Mild Cognitive Impairment
Genetic Studies of Early-onset Dementia
Impacts of Kebbi Robot Intervention for Older Adults With Mild Dementia
A Comparison of the Efficacy of Different Rehabilitation Strategies in Mild Cognitive Impairment
Multicomponent Intervention to Improve Cognitive Abilities in Older Adults With Mild Cognitive Impairment
A Multifocal tDCS-EEG Protocol for Improving Symptoms of Mild Cognitive Impairment and Early Dementia
Culturally Familiar Nostalgic VR Cognitive Training for Older Adults
Biomarker-based Trial of NPC-1 for Alzheimer's Pathology
Exploring the Impact of Dementia Prevention Programs Using Robots as Intervention Tools on Community Elderly
Improving Dementia Care in Primary Practice
InRAD Observational Study
Italian Validation of the Dynamic Neurocognitive Adaptation (dNA) Scale and Its Correlation With Neurocognitive Variables
Feasibility Study of 'SuperBrain BOOM' for Mild Cognitive Impairment Patients